MGMT-Methylated Glioblastoma — Trials

MGMT-Methylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 5
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Baptist Health South Florida
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05432804	Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment	recruiting	Phase 1 / Phase 2	97	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT07754734	STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation	not yet recruiting	Phase 2	138	Dongguan People's HospitalOTHER_GOV	0	Aug 10, 2026